| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |